Search Results - "Narula, Jeremy A. Bravo"

Next‐generation of melanoma researchers: Trainee perspectives from around the world by Webster, Marie R., Brathwaite, Roderick, Narula, Jeremy A. Bravo, Elad, Vissy M., Ma, Yanni, Ng, Mei Fong, Moraes Junior, Manoel Oliveira, Shabangu, Majahonkhe, Tsiavou, Christina, Villanueva, Jessie, Rebecca, Vito W.

“…The Society for Melanoma Research (SMR) was created 20 years ago and has unequivocally contributed to the vast progress of the field, particularly for the…”
Get full text

ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma by Jagirdar, Kasturee, Portuallo, Marie E., Wei, Meihan, Wilhide, Matthew, Bravo Narula, Jeremy A., Robertson, Bailey M., Alicea, Gretchen M., Aguh, Crystal, Xiao, Min, Godok, Tetiana, Fingerman, Dylan, Brown, Gregory Schuyler, Herlyn, Meenhard, Elad, Vissy M., Guo, Xinyu, Toska, Eneda, Zabransky, Daniel J., Wubbenhorst, Bradley, Nathanson, Katherine L., Kwatra, Shawn, Goyal, Yogesh, Ji, Hongkai, Liu, Qin, Rebecca, Vito W.

“…Patients with metastatic acral lentiginous melanoma (ALM) suffer worse outcomes relative to patients with other forms of cutaneous melanoma (CM), and do not…”
Get full text

Abstract 419: Elevated Akt/mTOR signaling drives therapy resistance in ALM by Narula, Jeremy A. Bravo, Rebecca, Vito W.

“…Metastatic acral lentiginous melanoma (ALM) is the most lethal subtype of cutaneous melanoma and effective therapies for patients have not been established…”
Get full text